Calendario›SNY›Study Based on Electronic Health RecOrds to Identify Patients at High-risk of Fabry DiseasE (HOPE Fabry)

Study Based on Electronic Health RecOrds to Identify Patients at High-risk of Fabry DiseasE (HOPE Fabry)

Ensayo de Sanofi en Fabry Disease (del registro, en inglés).

Fase

no aplica

Estado

Completado

Participantes

15

previstos

Centros

1

Fin del objetivo primario

dic 2023

fecha real

Qué significa cada fase y cada estado.

Estudio observacional. Comenzó en jul 2023.

Qué mide

Number and proportion of patients at high-risk for FD in the CCAD EMR database (del registro, en inglés) (hasta 6 meses)

Cómo lo describe el promotor

En el documentoEn inglés, del registroPrimary objective: To estimate the prevalence of patients who are at high-risk for Fabry Disease (FD) in the Cleveland Clinic, Abu Dhabi (CCAD) United Arab Emirates (EMR) database from May 2016 to May 2022, according to the predictive algorithm (i.e., feasibility assessment eligibility criteria) Secondary objectives: * To estimate the prevalence of FD among patients at high-risk for FD (i.e., among enrolled patients) * To characterize the patient profile, overall and in Cohorts 1 and 2 * To describe the most common characteristics among positive FD patients and negative FD patients

Más ensayos de SNY

Todos los de SNY, en su ficha.

Ficha completa en ClinicalTrials.gov (NCT05671770), actualizada en mar 2024.